Search research articles
Contact Us
Filters
Showing results (51-60 of 83) with videos related to
Page
of 9
Sort By:
Plos One
|
April 5, 2014
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells
Marc Cartellieri, Stefanie Koristka, Claudia Arndt, et al.
ACS Sensors
|
February 10, 2023
Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies
Diana Isabel Sandoval Bojórquez, Željko Janićijević, Brenda Palestina Romero, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 8, 2019
Tonic Signaling and Its Effects on Lymphopoiesis of CAR-Armed Hematopoietic Stem and Progenitor Cells
Susann Albert, Stefanie Koristka, Alexander Gerbaulet, et al.
ACS Sensors
|
August 24, 2023
Correction to Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies
Diana Isabel Sandoval Bojórquez, Željko Janićijević, Brenda Palestina Romero, et al.
Cancers
|
April 12, 2022
Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma
Ayşe Sedef Köseer, Liliana R Loureiro, Justyna Jureczek, et al.
Plos One
|
February 2, 2011
A novel modular antigen delivery system for immuno targeting of human 6-sulfo LacNAc-positive blood dendritic cells (SlanDCs)
Claudia C Bippes, Anja Feldmann, Slava Stamova, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 24, 2025
Microphysiological Solid Tumor Models in Hydrogel Beads for CAR T Cell Immunotherapy Evaluation
Xuan Peng, Željko Janićijević, Liliana R Loureiro, et al.
Oncotarget
|
January 10, 2018
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
Nicola Mitwasi, Anja Feldmann, Ralf Bergmann, et al.
NPJ Precision Oncology
|
February 9, 2025
RevCAR-mediated T-cell response against PD-L1-expressing cells turns suppression into activation
Eugenia Crespo, Liliana R Loureiro, Antonia Stammberger, et al.
Frontiers in Pharmacology
|
February 23, 2023
Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy
Claudia Arndt, Antje Tunger, Rebekka Wehner, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 83) with videos related to
Sort By:
Page
of 9
Plos One
|
April 5, 2014
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells
Marc Cartellieri, Stefanie Koristka, Claudia Arndt, et al.
ACS Sensors
|
February 10, 2023
Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies
Diana Isabel Sandoval Bojórquez, Željko Janićijević, Brenda Palestina Romero, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 8, 2019
Tonic Signaling and Its Effects on Lymphopoiesis of CAR-Armed Hematopoietic Stem and Progenitor Cells
Susann Albert, Stefanie Koristka, Alexander Gerbaulet, et al.
ACS Sensors
|
August 24, 2023
Correction to Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies
Diana Isabel Sandoval Bojórquez, Željko Janićijević, Brenda Palestina Romero, et al.
Cancers
|
April 12, 2022
Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma
Ayşe Sedef Köseer, Liliana R Loureiro, Justyna Jureczek, et al.
Plos One
|
February 2, 2011
A novel modular antigen delivery system for immuno targeting of human 6-sulfo LacNAc-positive blood dendritic cells (SlanDCs)
Claudia C Bippes, Anja Feldmann, Slava Stamova, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 24, 2025
Microphysiological Solid Tumor Models in Hydrogel Beads for CAR T Cell Immunotherapy Evaluation
Xuan Peng, Željko Janićijević, Liliana R Loureiro, et al.
Oncotarget
|
January 10, 2018
Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
Nicola Mitwasi, Anja Feldmann, Ralf Bergmann, et al.
NPJ Precision Oncology
|
February 9, 2025
RevCAR-mediated T-cell response against PD-L1-expressing cells turns suppression into activation
Eugenia Crespo, Liliana R Loureiro, Antonia Stammberger, et al.
Frontiers in Pharmacology
|
February 23, 2023
Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy
Claudia Arndt, Antje Tunger, Rebekka Wehner, et al.
Page
of 9